Crossmark

Design, synthesis, and multitarget evaluation of novel quinolone-based heterocyclic derivatives as acetyl cholinesterase inhibitors for Alzheimer’s disease therapy

Crossref DOI link: https://doi.org/10.1186/s43094-026-00967-y

Published Online: 2026-03-30

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Dobariya, Anjali M.

Vaghela, Vipul M.

Buddhadev, Sheetal

Prajapati, Bhupendra https://orcid.org/0000-0001-8242-4541
License Information

Text and Data Mining valid from 2026-03-30

Version of Record valid from 2026-03-30
More Information

Article History

Received: 3 September 2025

Accepted: 11 March 2026

First Online: 30 March 2026

Declarations

:

: Each step of animal handling process including administration and disposal was followed as per CPCSE guideline, A.R.College of Pharmacy and G.H. Patel institute of pharmacy with approval number CPCSEA/IAEC/ARCP/2022-23/06.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below